Weina Li

707 total citations
19 papers, 536 citations indexed

About

Weina Li is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Weina Li has authored 19 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 1 paper in Infectious Diseases. Recurrent topics in Weina Li's work include MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (6 papers) and RNA modifications and cancer (4 papers). Weina Li is often cited by papers focused on MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (6 papers) and RNA modifications and cancer (4 papers). Weina Li collaborates with scholars based in China, Sweden and Hong Kong. Weina Li's co-authors include Yu Deng, Peng Zhang, Qian Chu, Kuo Zhang, Qiang Hao, Yingqi Zhang, Wangqian Zhang, Chenlin Liu, Shuning Wang and Xiaoju Li and has published in prestigious journals such as ACS Nano, Advanced Science and Cancer Letters.

In The Last Decade

Weina Li

17 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weina Li China 8 370 180 162 88 77 19 536
Yuan Dang China 14 368 1.0× 290 1.6× 155 1.0× 111 1.3× 72 0.9× 35 660
Fubing Li China 15 544 1.5× 162 0.9× 154 1.0× 66 0.8× 53 0.7× 30 787
Kun Zhou China 13 459 1.2× 159 0.9× 70 0.4× 81 0.9× 54 0.7× 27 666
Ruo Chen China 13 371 1.0× 207 1.1× 132 0.8× 157 1.8× 213 2.8× 37 651
Jia You China 15 332 0.9× 227 1.3× 84 0.5× 120 1.4× 53 0.7× 32 620
Géraldine Rios France 8 289 0.8× 212 1.2× 71 0.4× 154 1.8× 96 1.2× 10 548
Leliang Zheng China 8 482 1.3× 360 2.0× 103 0.6× 80 0.9× 82 1.1× 13 645
Danfeng Guo China 13 367 1.0× 166 0.9× 103 0.6× 227 2.6× 51 0.7× 23 639
Haining Li China 11 237 0.6× 139 0.8× 141 0.9× 149 1.7× 110 1.4× 22 482
Jieqiong Zhang China 9 264 0.7× 106 0.6× 178 1.1× 257 2.9× 70 0.9× 18 554

Countries citing papers authored by Weina Li

Since Specialization
Citations

This map shows the geographic impact of Weina Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weina Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weina Li more than expected).

Fields of papers citing papers by Weina Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weina Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weina Li. The network helps show where Weina Li may publish in the future.

Co-authorship network of co-authors of Weina Li

This figure shows the co-authorship network connecting the top 25 collaborators of Weina Li. A scholar is included among the top collaborators of Weina Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weina Li. Weina Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Weina, et al.. (2025). Expression, characterization and anti-colon cancer activity of recombinant ginseng peptides with amino acid tandem repeats. Protein Expression and Purification. 229. 106663–106663. 1 indexed citations
3.
Wang, Fan, et al.. (2025). A ROR1 targeted bispecific T cell engager shows high potency in the pre-clinical model of triple negative breast cancer. Breast Cancer Research. 27(1). 47–47. 2 indexed citations
4.
Li, Weina, et al.. (2025). Comparative Study of Chinese and Western Cultural Heritage Reporting: A CDS Perspective. International Journal of English Literature and Social Sciences. 10(4). 311–323. 1 indexed citations
5.
Li, Weina, et al.. (2024). Venetoclax for an ATRA and ATO resistance acute promyelocytic leukemia patient with TNRC18::RARA fusion gene. Leukemia Research Reports. 22. 100482–100482. 1 indexed citations
6.
Wang, Mao, et al.. (2024). MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1. Protein and Peptide Letters. 31(7). 559–568. 2 indexed citations
8.
Liu, Xiao, Zhengcong Cao, Weizhong Wang, et al.. (2023). Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma. ACS Nano. 17(17). 16432–16447. 78 indexed citations
9.
Ding, Jian, et al.. (2023). Emerging role of engineered exosomes in nonalcoholic fatty liver disease. World Journal of Hepatology. 15(3). 386–392.
10.
Li, Feng, et al.. (2023). Long non-coding RNA HANR modulates the glucose metabolism of triple negative breast cancer via stabilizing hexokinase 2. Heliyon. 10(1). e23827–e23827. 2 indexed citations
11.
Li, Feng, et al.. (2023). (R)-9bMS Inhibited the Protein Synthesis and Autophagy of TripleNegative Breast Cancer Cells via Regulating miR-4660/mTOR Axis. Protein and Peptide Letters. 30(4). 295–303. 2 indexed citations
12.
He, Fei, Weina Li, Xinxin Li, et al.. (2022). Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice. Theranostics. 12(4). 1816–1828. 35 indexed citations
13.
Li, Xiaoju, Qianqian Yu, Chenlin Liu, et al.. (2022). Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 48 indexed citations
14.
Li, Weina, et al.. (2022). MicroRNA-137 Inhibits Esophageal Squamous Cell Carcinoma by DownregulatingDAAM1. Protein and Peptide Letters. 29(10). 882–890. 1 indexed citations
15.
Li, Weina, et al.. (2021). microRNA-506-3p suppresses the proliferation of triple negative breast cancer cells via targeting SNAI2. Molecular & Cellular Toxicology. 17(4). 513–522. 1 indexed citations
16.
Zhang, Sheng‐Xiao, et al.. (2021). Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis. Molecular Medicine Reports. 23(6). 7 indexed citations
17.
Gao, Yuan, Xiaoju Li, Cheng Zeng, et al.. (2020). CD63+ Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22. Advanced Science. 7(21). 2002518–2002518. 125 indexed citations
18.
Li, Weina, Yu Deng, Qian Chu, & Peng Zhang. (2019). Gut microbiome and cancer immunotherapy. Cancer Letters. 447. 41–47. 189 indexed citations
19.
Yang, Muyang, Jiajia Chen, Mengying Xu, et al.. (2019). Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity. Journal of Experimental & Clinical Cancer Research. 38(1). 351–351. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026